Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04417621
Recruitment Status : Active, not recruiting
First Posted : June 4, 2020
Last Update Posted : July 25, 2022
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 3, 2022
Estimated Study Completion Date : March 16, 2023